Acknowledgement
The authors thank H. Nikki March, PhD, from the Edanz Group (https://en-author-services.edanz.com/ac) for editing the draft of this manuscript.
References
- Hoffman BP, GrayzeL DM. Benign tumors of the duodenum. Am J Surg 1945;70:394-400. https://doi.org/10.1016/0002-9610(45)90190-5
- Darling RC, Welch CE. Tumors of the small intestine. N Engl J Med 1959;260:397-408. https://doi.org/10.1056/NEJM195902262600901
- Shukla SK, Elias EG. Primary neoplasms of the duodenum. Surg Gynecol Obstet 1976;142:858-860. https://doi.org/10.1515/9783112417362-080
- Alwmark A, Andersson A, Lasson A. Primary carcinoma of the duodenum. Ann Surg 1980;191:13-18. https://doi.org/10.1097/00000658-198001000-00003
- Lim CH, Cho YS. Nonampullary duodenal adenoma: current understanding of its diagnosis, pathogenesis, and clinical management. World J Gastroenterol 2016;22:853-861. https://doi.org/10.3748/wjg.v22.i2.853
- Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996;25:722-728. https://doi.org/10.1093/ije/25.4.722
- Goda K, Kikuchi D, Yamamoto Y, et al. Endoscopic diagnosis of superficial non-ampullary duodenal epithelial tumors in Japan: multicenter case series. Dig Endosc 2014;26 Suppl 2:23-29. https://doi.org/10.1111/den.12277
- Howe JR, Karnell LH, Menck HR, et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer 1999;86:2693-2706. https://doi.org/10.1002/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U
- Zar N, Holmberg L, Wilander E, et al. Survival in small intestinal adenocarcinoma. Eur J Cancer 1996;32A:2114-2119. https://doi.org/10.1016/S0959-8049(96)00244-4
- Dabaja BS, Suki D, Pro B, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-526. https://doi.org/10.1002/cncr.20404
- Kawai T, Takeuchi M, Fukuzawa M. Gastric atrophy prevent from incidence of duodenal tumor? J Clin Biochem Nutr 2017;60:219.
- Kakushima N, Ono H, Yoshida M, et al. Characteristics and risk factors for sporadic non-ampullary duodenal adenocarcinoma. Scand J Gastroenterol 2017;52:1253-1257. https://doi.org/10.1080/00365521.2017.1369563
- von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495-1499. https://doi.org/10.1016/j.ijsu.2014.07.013
- Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112. https://doi.org/10.1007/s10120-011-0041-5
- Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002;51:130-131. https://doi.org/10.1136/gut.51.1.130
- Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1:87-97. https://doi.org/10.1055/s-0028-1098086
- Sakaki N, Momma K, Egawa N, et al. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 1995;7 Suppl 1:S59-S62.
- Kamada T, Haruma K, Inoue K, et al. Helicobacter pylori infection and endoscopic gastritis: Kyoto classification of gastritis. Nihon Shokakibyo Gakkai Zasshi 2015;112:982-993.
- Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013;48:452-458. https://doi.org/10.1038/bmt.2012.244
- Murray MA, Zimmerman MJ, Ee HC. Sporadic duodenal adenoma is associated with colorectal neoplasia. Gut 2004;53:261-265. https://doi.org/10.1136/gut.2003.025320
- Wu ZJ, Lin Y, Xiao J, et al. Clinical significance of colonoscopy in patients with upper gastrointestinal polyps and neoplasms: a meta-analysis. PLoS One 2014;9:e91810.
- Negri E, Bosetti C, La Vecchia C, et al. Risk factors for adenocarcinoma of the small intestine. Int J Cancer 1999;82:171-174. https://doi.org/10.1002/(SICI)1097-0215(19990719)82:2<171::AID-IJC3>3.0.CO;2-T
- Ushiku T, Arnason T, Fukayama M, et al. Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol 2014;38:1484-1493. https://doi.org/10.1097/PAS.0000000000000278
- Toba T, Inoshita N, Kaise M, et al. Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency. J Gastroenterol 2018;53:64-70. https://doi.org/10.1007/s00535-017-1327-0
- Minatsuki C, Yamamichi N, Inada KI, et al. Expression of gastric markers is associated with malignant potential of nonampullary duodenal adenocarcinoma. Dig Dis Sci 2018;63:2617-2625. https://doi.org/10.1007/s10620-018-5179-0
- Harris AW, Gummett PA, Walker MM, et al. Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut 1996;39:513-520. https://doi.org/10.1136/gut.39.4.513
- Kushima R, Manabe R, Hattori T, et al. Histogenesis of gastric foveolar metaplasia following duodenal ulcer: a definite reparative lineage of Brunner's gland. Histopathology 1999;35:38-43. https://doi.org/10.1046/j.1365-2559.1999.00681.x
- Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008;1:329-338. https://doi.org/10.1158/1940-6207.CAPR-08-0109
- Navarro Silvera SA, Mayne ST, Risch H, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer 2008;123:852-860. https://doi.org/10.1002/ijc.23544
- Chen KH, Mukaisho K, Sugihara H, et al. High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barrett's esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux model. Cancer Sci 2007;98:1683-1688. https://doi.org/10.1111/j.1349-7006.2007.00605.x
- Mukaisho K, Nakayama T, Hagiwara T, et al. Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol 2015;6:412.
- Niwa A, Kuwano S, Tomita H, et al. The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum. Oncotarget 2017;8:41078-41090. https://doi.org/10.18632/oncotarget.17051
- Yoshida M, Shimoda T, Abe M, et al. Clinicopathological characteristics of non-ampullary duodenal tumors and their phenotypic classification. Pathol Int 2019;69:398-406. https://doi.org/10.1111/pin.12829
- Maruoka D, Arai M, Ishigami H, et al. Sporadic nonampullary duodenal adenoma/carcinoma is associated with not only colon adenoma/carcinoma but also gastric cancer: association of location of duodenal lesions with comorbid diseases. Scand J Gastroenterol 2015;50:333-340. https://doi.org/10.3109/00365521.2014.1003399
- Kamada T, Haruma K, Ito M, et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter 2015;20:192-198. https://doi.org/10.1111/hel.12193
- Kakushima N, Kanemoto H, Tanaka M, et al. Treatment for superficial non-ampullary duodenal epithelial tumors. World J Gastroenterol 2014;20:12501-12508. https://doi.org/10.3748/wjg.v20.i35.12501
- Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998;7:243-251.